WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...
People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...
Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...